Brensocatib, newly approved by the FDA for noncystic fibrosis bronchiectasis (NCFB), was also associated with improvements in lung structure, on the basis of data from a substudy of 100 individuals ...
In preclinical models, the inhalation of a mixture of living Lactobacilli bacteria attenuated pulmonary inflammation and improved lung function and structure for the chronic lung diseases ...
High levels of phenotypic age acceleration (PhenoAgeAccel) were found to have a more significant effect on lung function in patients with chronic obstructive pulmonary disease (COPD), older patients, ...
In a recent study posted to the bioRxiv preprint server, researchers develop the ‘crystal ribcage,’ a transparent ribcage for real-time lung imaging at cellular resolution. Study: Crystal Ribcage: A ...
Please provide your email address to receive an email when new articles are posted on . Higher levels of a biomarker for propylene oxide signaled worse measures of FVC and FEV 1. This relationship is ...
Biological therapy was associated with significant changes in lung structure and, by extension, improved lung function in individuals with chronic obstructive pulmonary disease (COPD) and T2 ...
Dr. Joshua K. Sabari explains how surgery, radiation and therapy may reduce lung capacity and shares steps survivors can take to protect their breathing health. In a recent video interview, Dr. Joshua ...
In A Nutshell Scientists found evidence that ancient coelacanths may have used their bony lungs to detect sound vibrations ...
This study, published in the journal Nature Communications, determined the mechanism of this live biotherapeutic product — a powder mixture of living Lactobacilli bacteria — to reduce neutrophilic ...